Literature DB >> 27121346

Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection.

Y M Lee1, T Y Sung1, W B Kim2, K W Chung1, J H Yoon1, S J Hong1.   

Abstract

BACKGROUND: This study evaluated the impact of lymph node-related factors on the risk of and site of recurrence in patients who had papillary thyroid carcinoma with lymph node metastasis in the lateral compartment (classified as pN1b).
METHODS: Patients underwent total thyroidectomy with unilateral modified radical neck dissection for classical papillary thyroid carcinoma. Risk factors for recurrence were evaluated according to the pattern of recurrence.
RESULTS: A total of 324 patients were included in the study. The median follow-up was 63 (range 14-181) months. Recurrence was detected in 47 patients (14·5 per cent). In the multivariable analysis, a maximum diameter of metastatic lymph nodes larger than 2·0 cm (hazard ratio (HR) 1·15, 95 per cent c.i. 1·06 to 1·25; P = 0·033) and a central compartment metastatic lymph node ratio of more than 0·42 (HR 3·35, 1·65 to 6·79; P < 0·001) were identified as independent risk factors for locoregional recurrence. Age 45 years or older (HR 5·69, 1·24 to 26·12; P = 0·025) and extranodal extension of metastasis (HR 12·71, 1·64 to 98·25; P = 0·015) were risk factors for distant metastasis. In subgroup analysis of locoregional recurrence, several lymph node-related factors affected the risk of recurrence according to the specific site of metastasis.
CONCLUSION: Lymph node-related factors are of importance for the risk of recurrence in patients with classical papillary thyroid carcinoma classified as pN1b.
© 2016 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27121346     DOI: 10.1002/bjs.10144

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  26 in total

1.  Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.

Authors:  Marco Raffaelli; Carmela De Crea; Luca Sessa; Serena Elisa Tempera; Amanda Belluzzi; Celestino P Lombardi; Rocco Bellantone
Journal:  Endocrine       Date:  2018-10-19       Impact factor: 3.633

2.  A Novel and Effective Model to Predict Skip Metastasis in Papillary Thyroid Carcinoma Based on a Support Vector Machine.

Authors:  Shuting Zhu; Qingxuan Wang; Danni Zheng; Lei Zhu; Zheng Zhou; Shiying Xu; Binbin Shi; Cong Jin; Guowan Zheng; Yefeng Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

3.  Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer.

Authors:  Hu Hei; Wenbo Gong; Chen Zheng; Bin Zhou; Jianwu Qin
Journal:  Endocrine       Date:  2022-04-07       Impact factor: 3.925

4.  Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.

Authors:  Jia-Wei Feng; An-Cheng Qin; Jing Ye; Hua Pan; Yong Jiang; Zhen Qu
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

5.  Development and validation of web-based nomograms for predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Yi Dou; Yingji Chen; Daixing Hu; Wei Xiong; Qi Xiao; Xinliang Su
Journal:  Gland Surg       Date:  2020-04

6.  Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma.

Authors:  Ke Jiang; Jianyong Lei; Wenjie Chen; Yanping Gong; Han Luo; Zhihui Li; Rixiang Gong; Jingqiang Zhu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

7.  Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma.

Authors:  Lei Jianyong; Li Zhihui; Gong Rixiang; Zhu Jingqiang
Journal:  BMC Cancer       Date:  2018-04-05       Impact factor: 4.430

8.  Predictive Factor of Large-Volume Central Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients Underwent Total Thyroidectomy.

Authors:  Jianhao Huang; Muye Song; Hongyan Shi; Ziyang Huang; Shujie Wang; Ying Yin; Yijie Huang; Jialin Du; Sanming Wang; Yongchen Liu; Zeyu Wu
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

9.  A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma.

Authors:  Zhou-Ci Zheng; Qing-Xuan Wang; Wei Zhang; Xiao-Hua Zhang; Du-Ping Huang
Journal:  Onco Targets Ther       Date:  2018-01-11       Impact factor: 4.147

10.  CUNR scoring system for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma.

Authors:  Jianyong Lei; Gengpeng Li; Zhihui Li; R X Rong; Jingqiang Zhu
Journal:  Oncotarget       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.